当前位置: X-MOL 学术Ann. Gen. Psychiatr. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD: what it is and what it isn’t
Annals of General Psychiatry ( IF 3.6 ) Pub Date : 2020-05-12 , DOI: 10.1186/s12991-020-00283-6
Louise Morgan 1
Affiliation  

Background PTSD is a chronic condition with high rates of comorbidity, but current treatment options are limited and not always effective. One novel approach is MDMA-assisted psychotherapy for people diagnosed with treatment-resistant PTSD, where MDMA is used as a catalyst to facilitate trauma processing during psychotherapy. The aim was to review all current research into MDMA-assisted psychotherapy for PTSD. Methods Articles were identified through PubMed and Science Direct for items published up to 31st March 2019 using terms “treatments for PTSD”, “drug treatments for PTSD”, “MDMA”, “MDMA pathway”, “MDMA-assisted psychotherapy” and “MDMA-assisted psychotherapy for PTSD”. Articles were identified through Google Scholar and subject-specific websites. Articles and relevant references cited in those articles were reviewed. Results Small-scale studies have shown reduced psychological trauma, however there has been widespread misunderstanding of the aims and implications of this work, most commonly the notion that MDMA is a ‘treatment for PTSD’, which to date has not been researched. This has harmful consequences, namely dangerous media reporting and impeding research progression in an already controversial field. Conclusions MDMA-assisted psychotherapy may help people who have experienced psychological trauma and who have not been able to resolve their problems through existing treatments, however more research is needed. If this is to get appropriate research attention, we must report this accurately and objectively.

中文翻译:

对被诊断患有难治性创伤后应激障碍的人进行 MDMA 辅助心理治疗:它是什么,不是什么

背景 PTSD 是一种具有高共病率的慢性疾病,但目前的治疗选择有限且并不总是有效。一种新方法是对被诊断患有难治性 PTSD 的人进行 MDMA 辅助心理治疗,其中 MDMA 被用作促进心理治疗期间创伤处理的催化剂。目的是回顾目前所有关于 MDMA 辅助心理治疗治疗 PTSD 的研究。方法 通过 PubMed 和 Science Direct 使用术语“PTSD 治疗”、“PTSD 药物治疗”、“MDMA”、“MDMA 途径”、“MDMA 辅助心理治疗”和“MDMA”来识别截至 2019 年 3 月 31 日发表的项目的文章- 创伤后应激障碍的辅助心理治疗”。文章是通过谷歌学术和特定主题的网站识别的。审查了这些文章中引用的文章和相关参考文献。结果 小规模研究表明心理创伤减少,但对这项工作的目的和影响存在广泛误解,最常见的是 MDMA 是一种“治疗 PTSD”的概念,迄今为止尚未对此进行研究。这会产生有害的后果,即危险的媒体报道和阻碍已经有争议的领域的研究进展。结论 MDMA 辅助心理治疗可以帮助那些经历过心理创伤并且无法通过现有治疗解决问题的人,但还需要更多的研究。如果这是为了得到适当的研究关注,我们必须准确客观地报告这一点。最常见的是,MDMA 是一种“治疗 PTSD”的概念,迄今为止尚未对此进行研究。这会产生有害的后果,即危险的媒体报道和阻碍已经有争议的领域的研究进展。结论 MDMA 辅助心理治疗可以帮助那些经历过心理创伤并且无法通过现有治疗解决问题的人,但还需要更多的研究。如果这是为了得到适当的研究关注,我们必须准确客观地报告这一点。最常见的是,MDMA 是一种“治疗 PTSD”的概念,迄今为止尚未对此进行研究。这会产生有害的后果,即危险的媒体报道和阻碍已经有争议的领域的研究进展。结论 MDMA 辅助心理治疗可以帮助那些经历过心理创伤并且无法通过现有治疗解决问题的人,但还需要更多的研究。如果这是为了得到适当的研究关注,我们必须准确客观地报告这一点。结论 MDMA 辅助心理治疗可以帮助那些经历过心理创伤并且无法通过现有治疗解决问题的人,但还需要更多的研究。如果这是为了得到适当的研究关注,我们必须准确客观地报告这一点。结论 MDMA 辅助心理治疗可以帮助那些经历过心理创伤并且无法通过现有治疗解决问题的人,但还需要更多的研究。如果这是为了得到适当的研究关注,我们必须准确客观地报告这一点。
更新日期:2020-05-12
down
wechat
bug